Davis Polk advised the underwriters on the registered offering of $300 million aggregate principal amount of 2.250% notes due 2020 and $450 million aggregate principal amount of 3.200%…
Davis Polk advised the initial purchasers on a Rule 144A/Regulation S offering by Tempur Sealy International, Inc. of $450 million aggregate principal amount of its 5.625% senior notes due…
Davis Polk served as special corporate disclosure counsel to the joint bookrunners on a Rule 144A/Regulation S offering by UBS Group Funding (Jersey) Limited of $1.5 billion aggregate…
Davis Polk advised Penumbra, Inc. on its SEC-registered initial public offering of 4,600,000 shares of common stock for an aggregate price to the public of approximately $138 million,…
Davis Polk is advising Dialog Semiconductor plc in connection with its $4.6 billion acquisition of Atmel Corporation. The transaction is subject to approval by Dialog and Atmel…
Davis Polk is advising IDG Capital Partners (“IDG”) in connection with its investment in SouFun Holdings Limited (“SouFun”). IDG and SouFun’s management (mainly founder and CEO Vincent Mo)…
Davis Polk represents Transcend Medical, Inc., an innovator in the field of Micro-Invasive Glaucoma Surgery, in a patent suit against Glaukos Corporation. Transcend has recently completed a…
Davis Polk is advising Fujian Thai Hot Investment Co., Ltd in connection with its purchase of approximately 51.5% of the common stock of Alliance HealthCare Services, Inc. Fujian Thai Hot…
On September 17, 2015, the U.S. Bankruptcy Court for the Eastern District of Virginia entered a final order approving $692 million of debtor-in-possession credit facilities (the “DIP…
Davis Polk advised the underwriters in connection with an SEC-registered Schedule B debt offering by The Korea Development Bank of $750 million aggregate principal amount of its 3.375%…